← Back to Search

Other

EHR Clinical Decision Support Tool for Dementia

N/A

Waitlist Available

Led By Catherine A Sarkisian, MD, MSPH

Research Sponsored by University of California, Los Angeles

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 month time point

Awards & highlights

Study Summary

This trial will study whether a quality improvement intervention using an EHR CDS tool can reduce the number of pill days per patient prescribed for older adults with ADRD.

Who is the study for?

This trial is for older adults with Alzheimer's or dementia at UCLA Health who have a primary care physician there. It includes doctors who've prescribed antipsychotics like Quetiapine or Risperidone recently. People with schizophrenia, bipolar disorder, Parkinson's disease, or recent antipsychotic prescriptions are excluded.Check my eligibility

What is being tested?

The study tests a new tool in electronic health records (EHR) to help doctors make better decisions about prescribing antipsychotics for dementia patients. The goal is to see if this tool can reduce unnecessary medication days per patient compared to usual care without the tool.See study design

What are the potential side effects?

Since the intervention involves using an EHR decision support tool rather than a medical treatment, it does not directly cause side effects. However, reducing low-value prescriptions may decrease potential medication-related side effects like drowsiness or confusion.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 month time point

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 month time point

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 month time point for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Contraceptives, Oral

Secondary outcome measures

Death within 90 days after enrollment

Hospitalizations (including psychiatric hospitalizations)

Number of patients who receive handout

+2 more

Trial Design

2Treatment groups

Experimental Treatment

Group I: EHR CDS toolExperimental Treatment1 Intervention

Multi-pronged electronic health record (EHR) clinical decision support (CDS) tool intervention to reduce physician prescriptions of new antipsychotic medications among older adults with ADRD

Group II: ControlExperimental Treatment1 Intervention

Physicians will not receive intervention and perform duties as usual.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor

1,528 Previous Clinical Trials

10,276,734 Total Patients Enrolled

National Institute on Aging (NIA)NIH

1,668 Previous Clinical Trials

28,004,947 Total Patients Enrolled

Catherine A Sarkisian, MD, MSPHPrincipal InvestigatorUniversity of California, Los Angeles

2 Previous Clinical Trials

1,240 Total Patients Enrolled

Media Library

Electronic Clinical Decision Support Tool (Other) Clinical Trial Eligibility Overview. Trial Name: NCT04851691 — N/A

Alzheimer's Disease Research Study Groups: Control, EHR CDS tool

Alzheimer's Disease Clinical Trial 2023: Electronic Clinical Decision Support Tool Highlights & Side Effects. Trial Name: NCT04851691 — N/A

Electronic Clinical Decision Support Tool (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04851691 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this trial currently have availability for participants?

"Although this clinical trial was posted on August 3rd 2021, and last updated on June 22nd 2022, it is not currently taking applications. However, there are 767 other medical studies actively recruiting patients presently."

Answered by AI

Recent research and studies

Journal of Hospital MedicineJournal

A Practical Framework for Understanding and Reducing Medical Overuse: Conceptualizing Overuse Through the Patient‐clinician Interaction

Morgan, Daniel J., Aaron L. Leppin, Cynthia D. Smith, and Deborah Korenstein. 2017. “A Practical Framework for Understanding and Reducing Medical Overuse: Conceptualizing Overuse Through the Patient‐clinician Interaction”. Journal of Hospital Medicine. Wiley. doi:10.12788/jhm.2738.

New England Journal of MedicineJournal

Swimming Against the Current — What Might Work to Reduce Low-value Care?

Colla, Carrie H.. 2014. “Swimming Against the Current — What Might Work to Reduce Low-value Care?”. New England Journal of Medicine. Massachusetts Medical Society. doi:10.1056/nejmp1404503.

Annals of Internal MedicineJournal

Atypical Antipsychotic Drugs and the Risk for Acute Kidney Injury and Other Adverse Outcomes in Older Adults

Hwang, Y. Joseph, Stephanie N. Dixon, Jeffrey P. Reiss, Ron Wald, Chirag R. Parikh, Sonja Gandhi, Salimah Z. Shariff, et al.. 2014. “Atypical Antipsychotic Drugs and the Risk for Acute Kidney Injury and Other Adverse Outcomes in Older Adults”. Annals of Internal Medicine. American College of Physicians. doi:10.7326/m13-2796.

BMJ Quality & SafetyJournal